Yuval Cohen is Chief Executive Officer and Director of Corbus Pharmaceuticals Holdings, Inc. (CRBP). The company reported total compensation of $3,750,125 for fiscal year 2025.
| Salary | $646,566 |
|---|---|
| Bonus | $373,682 |
| Stock awards | $666,699 |
| Option awards | $2,039,294 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $23,884 |
| Total | $3,750,125 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Corbus Pharmaceuticals Holdings, Inc. filed April 2, 2026, accession 0001193125-26-140363.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and Director | $646,566 | $373,682 | $666,699 | $2,039,294 | $0 | $0 | $23,884 | $3,750,125 |
| FY2024 | Chief Executive Officer and Director | $621,883 | $380,868 | $1,700,781 | $1,518,871 | $0 | $0 | $23,035 | $4,245,438 |
Totals as disclosed in each year's own compensation disclosure for Corbus Pharmaceuticals Holdings, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Yuval Cohen this page | Chief Executive Officer and Director | $3,750,125 |
| Dominic Smethurst | Chief Medical Officer | $1,800,142 |
| Sean Moran | Chief Financial Officer | $1,789,423 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Corbus Pharmaceuticals Holdings, Inc. compensation brief.
Yuval Cohen's compensation sits inside Corbus Pharmaceuticals Holdings, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Corbus Pharmaceuticals Holdings, Inc. (CRBP) compensation brief